ArticleACS applied materials & interfaces2026
Dual-Frequency Ultrasound Enhances Cavitation of Microdroplets for Controlled Scaffold Porosity in Tissue Engineering.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of porous scaffolds with tunable mechanical and structural properties is essential for advancing tissue engineering strategies. In this study, we present a noninvasive, adjustable method for generating porous collagen scaffolds by utilizing micron-sized phase-shift droplets in combination with dual-frequency ultrasound. These microdroplets, generated via a microfluidic chip and composed of a liquid perfluoropentane core stabilized by a phospholipid shell, were embedded within collagen hydrogels and served as ultrasound-responsive cavitation nuclei. A 3.5 MHz imaging transducer was employed to trigger acoustic droplet vaporization of the embedded microdroplets, transitioning them into microbubbles. Then, a 200 kHz therapeutic transducer induced bubble oscillation and collapse, leading to localized pore formation. This combined ultrasound strategy enabled both vaporization and bubble implosion at reduced pressure thresholds compared to conventional acoustic droplet vaporization methods. Theoretical modeling using the Marmottant model predicted microbubble dynamics and corresponding pore sizes, which were validated through scanning electron microscopy and histological analysis. Ultrasound-treated scaffolds containing droplets exhibited significantly increased porosity of 56.53 ± 3.91% compared to untreated controls, with a pore diameter of 39.42 ± 10.28 μm, observed via scanning electron microscopy. Rheological analysis revealed enhanced elasticity and structural resilience in ultrasound-treated scaffolds. Finally, in vitro studies confirmed that fibroblast viability remained high within the treated scaffolds, with cells observed in close proximity to ultrasound-generated pores. This work introduces a tunable and clinically relevant strategy for fabricating functional scaffolds that could support tissue regeneration and customizable healing environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.